AlenCiken

In-Line Q4 EPS Analyst Sees Better 2nd-Half

NYSE:CSLT   None
Castlight Health (NYSE: CSLT) reported Q4 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $40.47 million.

GUIDANCE:

Castlight Health sees FY2019 EPS of $0.00-$0.03, versus the consensus of $0.01. Castlight Health sees FY2019 revenue of $153-158 million, versus the consensus of $159.77 million.

www.barchart.com/sto...s-whats-in-the-cards

www.fool.com/investi...ed-24-on-friday.aspx


면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.